
The FDA had accepted for review Tris Pharma's New Drug Application for its extended-release liquid amphetamine to treat ADHD in children.
The FDA had accepted for review Tris Pharma's New Drug Application for its extended-release liquid amphetamine to treat ADHD in children.
The FDA is warning health care professionals about the risk for dosing errors with ceftolozane and tazobactam (Zerbaxa).
The FDA has cleared Roche's cobas Strep A test for use by health care professionals in non-traditional settings, including pharmacies and physician offices.
System deactivates prescription drugs through technology that bonds to pharmaceutical compounds.
Type 2 diabetes drugs could lead to complications that cause hospitalization.
Technology that can safely dispose of unused prescription medications is now available directly to consumers online.
A class of type 2 diabetes drugs could lead to a serious complication that might require hospitalization.
Elite Pharmaceuticals has launched a generic version of Atarax and Vistaril in 3 tablet strengths.
Unauthorized user could interfere with functioning and modify the drug dosage.
The FDA is actively investigating vulnerabilities identified in Hospira's LifeCare PCA3 and PCA5 infusion pump systems.
AstraZeneca and Abbott are teaming up to develop companion diagnostic blood tests that will identify patients with severe asthma who would benefit most from biological tralokinumab therapy.
The Arctic Front Advance ST Cryoablation Catheter is approved for use in patients with drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation.
AbbVie, Roche, and Genentech are collectively developing the drug to treat relapsed or refractory CLL patients with the 17p deletion genetic mutation.
Particulate matter found in 8 lots of Adrucil 50 mg/mL.
Mylan has begun shipping its generic version of Teva's Seasonale extended-cycle birth control pill.
Teva is voluntarily recalling select lots of intravenous fluorouracil (Adrucil).
The FDA has granted priority review to expand the use of AstraZeneca's ticagrelor (Brilinta).
The FDA is requesting more data on the safety and efficacy of certain health care antiseptic active ingredients.
Pfizer seeking to expand approved use of Xalkori to patients with ROS1-positive non-small cell lung cancer.
The FDA has awarded Breakthrough Therapy status to crizotinib (Xalkori) for ROS1-positive non-small cell lung cancer.
Meter can test glucose levels within 5 seconds.
Selumetinib treats a rare disease where cancer cells form within eye tissues.
GlaxoSmithKline has voluntarily recalled all remaining FluLaval Quadrivalent Thimerosal-Free prefilled flu vaccine syringes.
Study showed a median overall survival of nearly 3 years with Zytiga plus prednisone.
Most patients who require inhalers for asthma or epinephrine autoinjectors for an allergic disease do not use the devices properly, according to a study.
The FDA has granted Orphan Drug Designation to AstraZeneca's selumetinib.
Abiraterone acetate (Zytiga) significantly prolongs survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer.
Abbott's new blood glucose meter is now widely available OTC without insurance co-pays.
Liquid bendamustine hydrochloride rapid infusion treats patients with chronic lymphocytic leukemia.
Treatments found to improve glycemic control.